Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Previscan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Therapies - In Press.Proof corrected by the author Available online since jeudi 20 octobre 2016 
Is this relevant?
2014
2014
To JNA Readers: A 77-year-old woman with a history of arterial hypertension, diabetes mellitus, obesity, renal insufficiency, and… Expand
  • figure 1
Is this relevant?
2013
2013
Resume Propos Plusieurs donnees recentes montrent que la qualite de l’anticoagulation des patients traites par les antivitamines… Expand
Is this relevant?
2013
2013
Purpose Recent data show that the quality of anticoagulation evaluated in patients receiving vitamin K antagonists (VKA) is not… Expand
Is this relevant?
2005
2005
INTRODUCTION Fluindione (Previscan) is an oral anticoagulant belonging to the vitamin K antagonist class and is very widely used… Expand
Is this relevant?
Review
2003
Review
2003
INTRODUCTION Fluindione (Previscan) is an oral anti-vitamin K anticoagulant, widely prescribed in France. Contrary to phenindione… Expand
Is this relevant?
2003
2003
Introduction. La fluindione (Previscan®), largement prescrite en France, est un anticoagulant de la famille des antivitamines K… Expand
Is this relevant?
2002
2002
PATIENTS AND METHODS Between 1997 and 2001, 150 children (one month to 16 years of age) were treated with oral anticoagulants… Expand
Is this relevant?
2001
2001
BACKGROUND Fluindione (Previscan) is an oral anticoagulant prescribed in relay to heparin therapy for deep venous thrombosis… Expand
Is this relevant?
2001
2001
Introduction. La fluindione (Previscan®) est un anticoagulant de la famille des antivitamines K, derive de l'indanedione. Les… Expand
Is this relevant?